Raphael Lutz
Impact in
-
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Multiple Myeloma Research and Treatments 7
-
- Protein Degradation and Inhibitors 3
- Co-authors
- Carsten Bokemeyer (2 shared papers)Anne Marie Asemissen (2 shared papers)Britta Besemer (2 shared papers)Hartmut Goldschmidt (7 shared papers)Katja Weisel (2 shared papers)Marieke Essers (3 shared papers)Axel Benner (2 shared papers)Diana Tichy (2 shared papers)
- Journals
- Blood (5 papers)Cancers (1 paper)Journal of Clinical Oncology (1 paper)Blood Advances (1 paper)Andrologia (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Raphael Lutz
9 papers receiving 51 citations
Peers
Comparison fields: 5 of 20
- Hematology 38
- Oncology 22
- Genetics 6
- Immunology 11
- Molecular Biology 31
Countries citing papers authored by Raphael Lutz
This map shows the geographic impact of Raphael Lutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Lutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Lutz more than expected).
Fields of papers citing papers by Raphael Lutz
This network shows the impact of papers produced by Raphael Lutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Lutz. The network helps show where Raphael Lutz may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Lutz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 15 | |
| 2 | 2022 | 15 | |
| 3 | 2019 | 10 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 2 | |
| 6 | 2011 | 2 | |
| 7 | 2018 | 2 | |
| 8 | 2009 | 1 | |
| 9 | 2010 | 1 | |
| 10 | 2019 | 0 | |
| 11 | 2021 | 0 |
About Raphael Lutz
Raphael Lutz is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Immunology, having authored 11 papers that have together received 51 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (2 papers), Mesenchymal stem cell research (2 papers), Immune Cell Function and Interaction (2 papers), Chemokine receptors and signaling (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Plant Genetic and Mutation Studies (1 paper). The work is most often cited by research in Hematology (38 citations), Oncology (22 citations), Genetics (6 citations), Immunology (11 citations) and Molecular Biology (31 citations). Raphael Lutz has collaborated with scholars based in Germany and United States. Frequent co-authors include Carsten Bokemeyer, Anne Marie Asemissen, Britta Besemer, Hartmut Goldschmidt, Katja Weisel, Marieke Essers, Axel Benner, Diana Tichy, Christoph Mann and Hannah J. Uckelmann. Their work appears in journals such as Blood, Cancers, Journal of Clinical Oncology, Blood Advances and Andrologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.